Scrip
Ziopharm stops enrolment in Phase II sarcoma trial early on positive data
15 October 2009
Malini Guha
Please Login to read the full article.
15 October 2009
Malini Guha
Ziopharm Oncology has stopped enrolment early in a randomised Phase II trial testing its intravenous chemotherapy drug palifosfamide (Zymafos, ZIO-201) in advanced sarcoma on positive interim data. The US company plans to initiate a registration trial, as early as the first half of next year, following...
Please Login to read the full article.
RELATED CONTENT
NEWS
- Vectibix clears PFS but survival hurdle still awaits in colorectal cancer
- Mixed Phase III results for Erbitux in first-line colorectal cancer
- GSK's Armala could rival Pfizer's Sutent in kidney cancer
- Personalised therapeutic cancer vaccine shows benefit in Phase III lymphoma trial
COMMENT
Other Informa Comment
EVENTS
22 March 2010
London, UK
12 April 2010
Orlando, Florida
13 April 2010
London, UK
JOB OF THE WEEK
Promote your vacancy here
DIRECTORY
Scrip Directory 2009
